Objectives: We retrospectively analyzed the long-term outcomes of simultaneous or staged urinary diversion and kidney transplantation. Patients and Methods: Between June 2001 and December 2012, 4 patients with dysfunctional bladder resulting from spina bifida (n = 3) or bladder contraction following urologic tuberculosis (n = 1) underwent cadaveric kidney transplantation and urinary diversion simultaneously (n = 3) or 6 months post-transplantation (n = 1). Urinary diversion consisted of cutaneous ureterostomy in 1 patient and ileal conduits in 3 patients. All patients were followed prospectively. Results: All 4 patients received deceased donor transplants. Median follow-up was 110.5 months (range 50-120). At the last follow-up, serum creatinine levels ranged from 1.1 to 1.8 mg/dl. One patient with a functioning graft died of severe cirrhosis 105 months following transplantation. Graft function remained stable without any severe complications in 3 patients. Hematoma (Clavien-Dindo grade IIIa) and urinary leakage (grade II) occurred in 1 patient in the early postoperative period, but no surgical revision was required. Two patients developed cytomegalovirus pneumonia. Urinary tract infection was a common problem in all patients. Conclusions: For patients with lower urinary tract dysfunction, simultaneous kidney transplantation and urinary diversion with an ileal conduit may be a safe, feasible approach, with a satisfactory long-term outcome.

Keywords:
Kidney transplantation, Dysfunctional bladder, Urinary diversion, Ileal conduit, Ureterostomy
1.
Hatch DA: Kidney transplantation in patients with an abnormal lower urinary tract. Urol Clin North Am 1994;21:311-320.
2.
Luke PP, Herz DB, Bellinger MF, et al: Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation 2003;76:1578-1582.
3.
Bricker EM: Bladder substitution after pelvic evisceration. Surg Clin North Am 1950;30:1511-1521.
4.
Warholm C, Berglund J, Andersson J, Tydén G: Renal transplantation in patients with urinary diversion: a case-control study. Nephrol Dial Transplant 1999;14:2937-2940.
5.
Koo HP, Bunchman TE, Flynn JT, et al: Renal transplantation in children with severe lower urinary tract dysfunction. J Urol 1999;161:240-245.
6.
Jacoby K, Banowsky LH: Renal transplantation into ileal conduits: results and long-term follow-up. Clin Transplant 1991;5:365-367.
7.
Cairns HS, Leaker B, Woodhouse CRJ, et al: Renal transplantation into abnormal lower urinary tract. Lancet 1991;338:1376-1379.
8.
Broniszczak D, Ismail H, Nachulewicz P, et al: Kidney transplantation in children with bladder augmentation or ileal conduit diversion. Eur J Pediatr Surg 2010;20:5-10.
9.
Surange RS, Johnson RW, Tavakoli A, et al: Kidney transplantation into an ileal conduit: a single center experience of 59 cases. J Urol 2003;170:1727-1730.
10.
Bilginer Y, Aki FT, Topaloglu R, et al: Renal transplantation in children with lower urinary tract dysfunction of different origin: a single-center experience. Transplant Proc 2008;40:85-86.
11.
Cerilli J, Anderson GW, Evans WE, et al: Renal transplantation in patients with urinary tract abnormalities. Surgery 1976;79:248-252.
12.
Thomalla JV, Mitchell ME, Leapman A, Filo RS: Renal transplantation into the reconstructed bladder. J Urol 1989;141:265-268.
13.
Kocot A, Spahn M, Loeser A, Lopau K, Gerharz EW, Riedmiller H: Long-term results of a staged approach: continent urinary diversion in preparation for renal transplantation. J Urol 2010;184:2038-2042.
14.
Rigamonti W, Capizzi A, Zacchello G, et al: Kidney transplantation into bladder augmentation or urinary diversion: long-term results. Transplantation 2005;80:1435-1440.
15.
Manassero F, Di Paola G, Mogorovich A, Giannarini G, Boggi U, Selli C: Orthotopic bladder substitute in renal transplant recipients: experience with Studer technique and literature review. Transpl Int 2011;24:943-948.
16.
Hamdi M, Mohan P, Little DM, et al: Successful renal transplantation in children with spina bifida: long term single center experience. Pediatr Transplant 2004;8:167-170.
17.
Power RE, O'Malley KJ, Little DM, et al: Long-term follow-up of cadaveric renal transplantation in patients with spina bifida. J Urol 2002;167:477-479.
18.
Djakovic N, Wagener N, Adams J, et al: Intestinal reconstruction of the lower urinary tract as a prerequisite for renal transplantation. BJU Int 2009;103:1555-1560.
19.
Hatch DA, Koyle MA, Baskin LS, et al: Kidney transplantation in children with urinary diversion or bladder augmentation. J Urol 2001;165:2265-2268.
20.
Coosemans W, Baert L, Kuypers D, et al: Renal transplantation onto abnormal urinary tract: ileal conduit urinary diversion. Transplant Proc 2001;33:2393-2394.
21.
Wang J, Xing N, Zhang X, et al: Orthotopic ileal neobladder reconstruction in patients with recurring bladder cancer after renal transplantation - a report of two cases and a review of the literature. Clin Transplant 2009;23:700-704.
22.
Khater N, Khauli R: Pseudorejection and true rejection after kidney transplantation: classification and clinical significance. Urol Int 2013;90:373-380.
23.
Crowe A, Cairns HS, Wood S, et al: Renal transplantation following renal failure due to urological disorders. Nephrol Dial Transplant 1998;13:2065-2069.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.